Literature DB >> 19405544

Structure-activity relations of nanolipoblockers with the atherogenic domain of human macrophage scavenger receptor A.

Nicole M Plourde1, Sandhya Kortagere, William Welsh, Prabhas V Moghe.   

Abstract

Oxidized low density lipoprotein (oxLDL) uptake by macrophages is mediated by scavenger receptors and leads to unregulated cholesterol accumulation. Micellar nanolipoblockers (NLBs) consist of alkyl chains and polyethylene glycol on mucic acid. NLBs functionalized with anionic groups inhibit oxLDL uptake via the scavenger receptor A (SR-A). Molecular modeling and docking approaches were used to understand the structure-activity relationship (SAR) between NLBs and SR-A. Six NLB models were docked to the SR-A homology model to investigate charge placement and clustering. NLB models with the most favorable binding energy were also the most effective oxLDL inhibitors in THP-1 macrophages. Mutant SR-A models were generated by replacing charged residues with alanine. All charged residues in the region were necessary, with Lys60, Lys63, and Lys66 having the greatest effect on binding. We hypothesize that structural studies aided by theoretical modeling and docking can be used to design promising NLB candidates with optimal binding properties.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19405544      PMCID: PMC2716033          DOI: 10.1021/bm8014522

Source DB:  PubMed          Journal:  Biomacromolecules        ISSN: 1525-7797            Impact factor:   6.988


  40 in total

1.  Protein secondary structure prediction based on position-specific scoring matrices.

Authors:  D T Jones
Journal:  J Mol Biol       Date:  1999-09-17       Impact factor: 5.469

2.  The PSIPRED protein structure prediction server.

Authors:  L J McGuffin; K Bryson; D T Jones
Journal:  Bioinformatics       Date:  2000-04       Impact factor: 6.937

3.  Microfibrillar structure of type I collagen in situ.

Authors:  Joseph P R O Orgel; Thomas C Irving; Andrew Miller; Tim J Wess
Journal:  Proc Natl Acad Sci U S A       Date:  2006-06-02       Impact factor: 11.205

4.  Cell targeting by a generic receptor-targeted polymer nanocontainer platform.

Authors:  Pavel Broz; Samantha M Benito; Cheeloong Saw; Peter Burger; Harald Heider; Matthias Pfisterer; Stephan Marsch; Wolfgang Meier; Patrick Hunziker
Journal:  J Control Release       Date:  2005-02-02       Impact factor: 9.776

5.  The lysine cluster in the collagen-like domain of the scavenger receptor provides for its ligand binding and ligand specificity.

Authors:  K Yamamoto; N Nishimura; T Doi; T Imanishi; T Kodama; K Suzuki; T Tanaka
Journal:  FEBS Lett       Date:  1997-09-08       Impact factor: 4.124

6.  Development and validation of a genetic algorithm for flexible docking.

Authors:  G Jones; P Willett; R C Glen; A R Leach; R Taylor
Journal:  J Mol Biol       Date:  1997-04-04       Impact factor: 5.469

7.  Nanoscale anionic macromolecules for selective retention of low-density lipoproteins.

Authors:  Evangelia Chnari; Hamed B Lari; Lu Tian; Kathryn E Uhrich; Prabhas V Moghe
Journal:  Biomaterials       Date:  2005-06       Impact factor: 12.479

8.  Dominant negative mutations of the scavenger receptor. Native receptor inactivation by expression of truncated variants.

Authors:  S Dejager; M Mietus-Snyder; A Friera; R E Pitas
Journal:  J Clin Invest       Date:  1993-08       Impact factor: 14.808

9.  2,4-Bis(octadecanoylamino)benzenesulfonic acid sodium salt as a novel scavenger receptor inhibitor with low molecular weight.

Authors:  Kazuya Yoshiizumi; Fumio Nakajima; Rika Dobashi; Noriyasu Nishimura; Shoji Ikeda
Journal:  Bioorg Med Chem Lett       Date:  2004-06-07       Impact factor: 2.823

10.  Nanoscale amphiphilic macromolecules as lipoprotein inhibitors: the role of charge and architecture.

Authors:  Jinzhong Wang; Nicole M Plourde; Nicole Iverson; Prabhas V Moghe; Kathryn E Uhrich
Journal:  Int J Nanomedicine       Date:  2007
View more
  17 in total

Review 1.  Designing polymers with sugar-based advantages for bioactive delivery applications.

Authors:  Yingyue Zhang; Jennifer W Chan; Alysha Moretti; Kathryn E Uhrich
Journal:  J Control Release       Date:  2015-09-28       Impact factor: 9.776

2.  Controllable inhibition of cellular uptake of oxidized low-density lipoprotein: structure-function relationships for nanoscale amphiphilic polymers.

Authors:  Nicole M Iverson; Sarah M Sparks; Bahar Demirdirek; Kathryn E Uhrich; Prabhas V Moghe
Journal:  Acta Biomater       Date:  2010-02-17       Impact factor: 8.947

3.  Dual use of amphiphilic macromolecules as cholesterol efflux triggers and inhibitors of macrophage athero-inflammation.

Authors:  Nicole M Iverson; Nicole M Plourde; Sarah M Sparks; Jinzhong Wang; Ekta N Patel; Pratik S Shah; Daniel R Lewis; Kyle R Zablocki; Gary B Nackman; Kathryn E Uhrich; Prabhas V Moghe
Journal:  Biomaterials       Date:  2011-08-03       Impact factor: 12.479

4.  Polymer brain-nanotherapeutics for multipronged inhibition of microglial α-synuclein aggregation, activation, and neurotoxicity.

Authors:  Neal K Bennett; Rebecca Chmielowski; Dalia S Abdelhamid; Jonathan J Faig; Nicola Francis; Jean Baum; Zhiping P Pang; Kathryn E Uhrich; Prabhas V Moghe
Journal:  Biomaterials       Date:  2016-10-04       Impact factor: 12.479

5.  Tartaric acid-based amphiphilic macromolecules with ether linkages exhibit enhanced repression of oxidized low density lipoprotein uptake.

Authors:  Dalia S Abdelhamid; Yingyue Zhang; Daniel R Lewis; Prabhas V Moghe; William J Welsh; Kathryn E Uhrich
Journal:  Biomaterials       Date:  2015-03-07       Impact factor: 12.479

6.  Nanoscale amphiphilic macromolecules with variable lipophilicity and stereochemistry modulate inhibition of oxidized low-density lipoprotein uptake.

Authors:  Dawanne E Poree; Kyle Zablocki; Allison Faig; Prabhas V Moghe; Kathryn E Uhrich
Journal:  Biomacromolecules       Date:  2013-07-08       Impact factor: 6.988

7.  Sugar-based amphiphilic nanoparticles arrest atherosclerosis in vivo.

Authors:  Daniel R Lewis; Latrisha K Petersen; Adam W York; Kyle R Zablocki; Laurie B Joseph; Vladyslav Kholodovych; Robert K Prud'homme; Kathryn E Uhrich; Prabhas V Moghe
Journal:  Proc Natl Acad Sci U S A       Date:  2015-02-17       Impact factor: 11.205

8.  Kinetically assembled nanoparticles of bioactive macromolecules exhibit enhanced stability and cell-targeted biological efficacy.

Authors:  Adam W York; Kyle R Zablocki; Daniel R Lewis; Li Gu; Kathryn E Uhrich; Robert K Prud'homme; Prabhas V Moghe
Journal:  Adv Mater       Date:  2012-01-02       Impact factor: 30.849

9.  Carbohydrate composition of amphiphilic macromolecules influences physicochemical properties and binding to atherogenic scavenger receptor A.

Authors:  Sarah Hehir; Nicole M Plourde; Li Gu; Dawanne E Poree; William J Welsh; Prabhas V Moghe; Kathryn E Uhrich
Journal:  Acta Biomater       Date:  2012-07-24       Impact factor: 8.947

10.  In silico design of anti-atherogenic biomaterials.

Authors:  Daniel R Lewis; Vladyslav Kholodovych; Michael D Tomasini; Dalia Abdelhamid; Latrisha K Petersen; William J Welsh; Kathryn E Uhrich; Prabhas V Moghe
Journal:  Biomaterials       Date:  2013-07-25       Impact factor: 12.479

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.